| Factors associated with COVID-19-related death using OpenSAFELY EJ Williamson, AJ Walker, K Bhaskaran, S Bacon, C Bates, CE Morton, ... Nature 584 (7821), 430-436, 2020 | 6140 | 2020 |
| Bad Science B Goldacre McClelland & Stewart, 2010 | 1120 | 2010 |
| Bad pharma: how drug companies mislead doctors and harm patients B Goldacre Macmillan, 2014 | 1083 | 2014 |
| OpenSAFELY: factors associated with COVID-19 death in 17 million patients EJ Williamson, AJ Walker, K Bhaskaran, S Bacon, C Bates, CE Morton, ... Nature 584 (7821), 430, 2020 | 719 | 2020 |
| OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients OpenSAFELY Collaborative, E Williamson, AJ Walker, K Bhaskaran, ... MedRxiv, 2020.05. 06.20092999, 2020 | 647 | 2020 |
| HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform K Bhaskaran, CT Rentsch, B MacKenna, A Schultze, A Mehrkar, CJ Bates, ... The lancet HIV 8 (1), e24-e32, 2021 | 524 | 2021 |
| Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational … R Mathur, CT Rentsch, CE Morton, WJ Hulme, A Schultze, B MacKenna, ... The Lancet 397 (10286), 1711-1724, 2021 | 455 | 2021 |
| Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records EJ Thompson, DM Williams, AJ Walker, RE Mitchell, CL Niedzwiedz, ... Nature communications 13 (1), 3528, 2022 | 451 | 2022 |
| Building evidence into education B Goldacre Department for Education, 2013 | 435 | 2013 |
| Why clinical trial outcomes fail to translate into benefits for patients C Heneghan, B Goldacre, KR Mahtani Trials 18, 1-7, 2017 | 375 | 2017 |
| Functional heterogeneity of left inferior frontal cortex as revealed by fMRI E Paulesu, B Goldacre, P Scifo, SF Cappa, MC Gilardi, I Castiglioni, ... Neuroreport 8 (8), 2011-2016, 1997 | 334 | 1997 |
| Test, learn, adapt: developing public policy with randomised controlled trials L Haynes, B Goldacre, D Torgerson Cabinet Office-Behavioural Insights Team, 2012 | 326 | 2012 |
| Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the … A Schultze, AJ Walker, B MacKenna, CE Morton, K Bhaskaran, JP Brown, ... The Lancet Respiratory Medicine 8 (11), 1106-1120, 2020 | 289 | 2020 |
| Who owns the data? Open data for healthcare P Kostkova, H Brewer, S De Lusignan, E Fottrell, B Goldacre, G Hart, ... Frontiers in public health 4, 7, 2016 | 280 | 2016 |
| What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid … JA Finegold, CH Manisty, B Goldacre, AJ Barron, DP Francis European journal of preventive cardiology 21 (4), 464-474, 2014 | 277 | 2014 |
| Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data A Matthews, E Herrett, A Gasparrini, T Van Staa, B Goldacre, L Smeeth, ... bmj 353, 2016 | 255 | 2016 |
| Compliance with legal requirement to report clinical trial results on ClinicalTrials. gov: a cohort study NJ DeVito, S Bacon, B Goldacre The Lancet 395 (10221), 361-369, 2020 | 253 | 2020 |
| COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time B Goldacre, H Drysdale, A Dale, I Milosevic, E Slade, P Hartley, ... Trials 20, 1-16, 2019 | 246 | 2019 |
| Case fatality risk of the SARS-CoV-2 variant of concern B. 1.1. 7 in England, 16 November to 5 February DJ Grint, K Wing, E Williamson, HI McDonald, K Bhaskaran, D Evans, ... Eurosurveillance 26 (11), 2100256, 2021 | 232 | 2021 |
| Opioid prescribing trends and geographical variation in England, 1998–2018: a retrospective database study HJ Curtis, R Croker, AJ Walker, GC Richards, J Quinlan, B Goldacre The Lancet Psychiatry 6 (2), 140-150, 2019 | 231 | 2019 |
